Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
AURA is expected to report earnings to rise 22.50% to -49 cents per share on March 31
Q4'25
Est.
$-0.49
Q3'25
Beat
by $0.06
Q2'25
Est.
$-0.47
Q1'25
Missed
by $0.07
Q4'24
Missed
by $0.08
The last earnings report on November 13 showed earnings per share of -40 cents, beating the estimate of -46 cents. With 174.35K shares outstanding, the current market capitalization sits at 342.92M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AURA showed earnings on November 13, 2025. You can read more about the earnings report here.